Inhibition of PDE5 restores depressed baroreflex sensitivity in renovascular hypertensive rats

Frontiers in Physiology

Volumn 7, Issue JAN, 2016, Pages

  Cavalcanti, Clênia de Oliveira ^a   Alves, Rafael R ^a   de Oliveira, Alessandro L ^a   Cruz, Josiane de Campos ^a   de França Silva, Maria do Socorro ^a   Braga, Valdir de Andrade ^a   Balarini, Camille de Moura ^a  

^a FEDERAL UNIVERSITY OF PARAÍBA   (Brazil)

Author keywords

Angiotensin II; Baroreflex; Nitric oxide; Resistant hypertension; Sildenafil

Indexed keywords

PHOSPHODIESTERASE V; SILDENAFIL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE REGULATION; BODY WEIGHT; CONTROLLED STUDY; DRUG EFFECT; ENZYME INHIBITION; HEART RATE; LIPID PEROXIDATION; NONHUMAN; ORGAN WEIGHT; OXIDATIVE STRESS; PRESSORECEPTOR REFLEX; RAT; RENOVASCULAR HYPERTENSION;

EID: 84962736071     PISSN: None     EISSN: 1664042X     Source Type: Journal    
DOI: 10.3389/fphys.2016.00015     Document Type: Article

References (57)

1. Aboutabl, M. E., Raafat, M., Maklad, Y. A., Kenawy, S. A., and El Din, A. G. (2008). Sildenafil augments the beneficial hemodynamic and histopathological effects of amlodipine in nitric oxide-deficient hypertensive rats: role of nitric oxide-cyclic GMP pathway. Pharmacol. Res. 57, 456-463. doi: 10.1016/j.phrs.2008.05.003.
2. Alves, N. F. B., Porpino, S. K. P., Monteiro, M. M. O., Gomes, E. R. M., and Braga, V. A. (2015). Coconut oil supplementation and physical exercise improves baroreflex sensitivity and oxidative stress in hypertensive rats. Appl. Physiol. Nutr. Metab. 400, 393-400. doi: 10.1139/apnm-2014-0351.
3. Balarini, C. M., Leal, M. A., Gomes, I. B. S., Pereira, T. M. C., Gava, A. L., Meyrelles, S. S., et al. (2013). Sildenafil restores endothelial function in the apolipoprotein E knockout mouse. J. Transl. Med. 11:3. doi: 10.1186/1479-5876-11-3.
4. Bivalacqua, T. J., Sussan, T. E., Gebska, M. A., Strong, T. D., Berkowitz, D. E., Biswal, S., et al. (2009). Sildenafil inhibits superoxide formation and prevents endothelial dysfunction in a mouse model of secondhand smoke induced erectile dysfunction. J. Urol. 181, 899-906. doi: 10.1016/j.juro.2008.10.062.
5. Bombarda, G., Sabino, J. P. J., Silva, C. A. A., Fazan, R., Salgado, M. C. O., and Salgado, H. C. (2011). Role of cGMP and cAMP in the hemodynamic response to intrathecal sildenafil administration. Clinics 66, 1407-1412. doi: 10.1590/S1807-59322011000800017.
6. Botelho-Ono, M. S., Pina, H. V., Sousa, K. H. F., Nunes, F. C., Medeiros, I. A., and Braga, V. A. (2011). Acute superoxide scavenging restores depressed baroreflex sensitivity in renovascular hypertensive rats. Auton. Neurosci. 159, 38-44. doi: 10.1016/j.autneu.2010.07.025.
7. Braga, V. A., Burmeister, M. A., Sharma, R. V., and Davisson, R. L. (2008). Cardiovascular responses to peripheral chemoreflex activation and comparison of different methods to evaluate baroreflex gain in conscious mice using telemetry. Am. J. Physiol. Regul. Integr. Comp. Physiol. 295, R1168-R1174. doi: 10.1152/ajpregu.90375.2008.
8. Braga, V. A., Medeiros, I. A., Ribeiro, T. P., França-Silva, M. S., Botelho-Ono, M. S., and Guimarães, D. D. (2011). Angiotensin-II-induced reactive oxygen species along the SFO-PVN-RVLM pathway: implications in neurogenic hypertension. Braz. J. Med. Biol. Res. 44, 871-876. doi: 10.1590/S0100-879X2011007500088.
9. Campagnaro, B. P., Gava, A. L., Meyrelles, S. S., and Vasquez, E. C. (2012). Cardiac-autonomic imbalance and baroreflex dysfunction in the renovascular angiotensin-dependent hypertensive mouse. Int. J. Hypertens. 2012:968123. doi: 10.1155/2012/968123.
10. Campos, R. R., Oliveira-Sales, E. B., Nishi, E. E., Boim, M. A., Dolnikoff, M. S., and Bergamaschi, C. T. (2011). The role of oxidative stress in renovascular hypertension. Clin. Exp. Pharmacol. Physiol. 38, 144-152. doi: 10.1111/j.1440-1681.2010.05437.x.
11. Carey, R. M. (2013). Resistant hypertension. Hypertension 61, 746-750. doi: 10.1161/HYPERTENSIONAHA.111.00601.
12. Chokshi, N. P., Grossman, E., and Messerli, F. H. (2013). Blood pressure and diabetes: vicious twins. Heart 99, 577-585. doi: 10.1136/heartjnl-2012-302029.
13. de Queiroz, T. M., Monteiro, M. M. O., and Braga, V. A. (2013). Angiotensin-II-derived reactive oxygen species on baroreflex sensitivity during hypertension: new perspectives. Front. Physiol. 4:105. doi: 10.3389/fphys.2013.00105.
14. Dias, A. T., Cintra, A. S., Frossard, J. C., Palomino, Z., Casarini, D. E., Gomes, I., et al. (2014a). Inhibition of phosphodiesterase 5 restores endothelial function in renovascular hypertension. J. Transl. Med. 12:250. doi: 10.1186/s12967-014-0250-x.
15. Dias, A. T., Rodrigues, B. P., Porto, M. L., Gava, A. L., Balarini, C. M., Freitas, F. P. S., et al. (2014b). Sildenafil ameliorates oxidative stress and DNA damage in the stenotic kidneys in mice with renovascular hypertension. J. Transl. Med. 12:35. doi: 10.1186/1479-5876-12-35.
16. Dopp, J. M., Agapitov, A. V., Sinkey, C. A., Haynes, W. G., and Phillips, B. G. (2013). Sildenafil increases sympathetically mediated vascular tone in humans. Am. J. Hypertens. 26, 762-769. doi: 10.1093/ajh/hpt018.
17. Fahning, B., Dias, A. T., Oliveira, J. P., Gava, A. L., Porto, M. L., Gomes, I. B., et al. (2015). Sildenafil Improves Vascular Endothelial Structure and Function in Renovascular Hypertension. Curr. Pharm. Biotechnol. 16, 823-831. doi: 10.2174/1389201016666150610161330.
18. Faselis, C., Doumas, M., and Papademetriou, V. (2011). Common secondary causes of resistant hypertension and rational for treatment. Int. J. Hypertens. 2011:236239. doi: 10.4061/2011/236239.
19. Fazan, R., Huber, D. A., Silva, C. A. A., Dias da Silva, V. J., Salgado, M. C. O., and Salgado, H. C. (2008). Sildenafil acts on the central nervous system increasing sympathetic activity. J. Appl. Physiol. 104, 1683-1689. doi: 10.1152/japplphysiol.01142.2007.
20. Ferreira-Melo, S. E., Yugar-Toledo, J. C., Coelho, O. R., De Luca, I. M., Tanus-Santos, J. E., Hyslop, S., et al. (2006). Sildenafil reduces cardiovascular remodeling associated with hypertensive cardiomyopathy in NOS inhibitor-treated rats. Eur. J. Pharmacol. 542, 141-147. doi: 10.1016/j.ejphar.2006.04.039.
21. Giusti, M. F., Sato, M. A., Cardoso, L. M., Braga, V. A., and Colombari, E. (2011). Central antioxidant therapy inhibits parasympathetic baroreflex control in conscious rats. Neurosci. Lett. 489, 115-118. doi: 10.1016/j.neulet.2010.11.077.
22. Goldblatt, B. Y. H., Lynch, J., Ramon, F., Ph, D., and Summerville, W. W. (1934). Studies on experimental hypertension. The production of persistent elevation of systolic blood pressure by means of renal ischtemia. J. Exp. Med. 59, 347-379. doi: 10.1084/jem.59.3.347.
23. Grassi, G., Mark, A., and Esler, M. (2015). The sympathetic nervous system alterations in human hypertension. Circ. Res. 116, 976-991. doi: 10.1161/CIRCRESAHA.116.303604.
24. Guimarães, D., Carvalho, C., and Braga, V. A. (2012). Scavenging of NADPH oxidase-derived superoxide anions improves depressed baroreflex sensitivity in spontaneously hypertensive rats. Clin. Exp. Pharmacol. Physiol. 39, 373-378. doi: 10.1111/j.1440-1681.2012.05679.x.
25. Guimarães, D. A., Rizzi, E., Ceron, C. S., Pinheiro, L. C., Gerlach, R. F., and Tanus-Santos, J. E. (2013). Atorvastatin and sildenafil lower blood pressure and improve endothelial dysfunction, but only atorvastatin increases vascular stores of nitric oxide in hypertension. Redox Biol. 1, 578-585. doi: 10.1016/j.redox.2013.11.004.
26. Irigoyen, M. C., and Krieger, E. M. (1998). Baroreflex control of sympathetic activity in experimental hypertension. Braz. J. Med. Biol. Res. 31, 1213-1220. doi: 10.1590/S0100-879X1998000900015.
27. Kishi, T., and Hirooka, Y. (2012). Oxidative stress in the brain causes hypertension via sympathoexcitation. Front. Physiol. 3:335. doi: 10.3389/fphys.2012.00335.
28. Kishi, T., Hirooka, Y., Sakai, K., Shigematsu, H., Shimokawa, H., and Takeshita, A. (2001). Overexpression of eNOS in the RVLM causes hypotension and bradycardia via GABA release. Hypertension 38, 896-901.
29. Koupparis, A. J., Jeremy, J. Y., Muzaffar, S., Persad, R., and Shukla, N. (2005). Sildenafil inhibits the formation of superoxide and the expression of gp47phox NAD[P]H oxidase induced by the thromboxane A2 mimetic, U46619, in corpus cavernosal smooth muscle cells. BJU Int. 96, 423-427. doi: 10.1111/j.1464-410X.2005.05643.x.
30. Leal, M. A., Balarini, C. M., Dias, A. T., Porto, M. L., Gava, A. L., Pereira, T. M. C., et al. (2015). Mechanisms of enhanced vasoconstriction in the mouse model of athero-sclerosis: the beneficial effects of sildenafil. Curr. Pharm. Biotechnol. 16, 517-530. doi: 10.2174/138920101606150407113458.
31. Monteiro, M. M. O., França-Silva, M. S., Alves, N. F. B., Porpino, S. K. P., and Braga, V. A. (2012). Quercetin improves baroreflex sensitivity in spontaneously hypertensive rats. Molecules 17, 12997-13008. doi: 10.3390/molecules171112997.
32. Navar, L. G., Zou, L., Von Thun, A., Tarng Wang, C., Imig, J. D., and Mitchell, K. D. (1998). Unraveling the mystery of goldblatt hypertension. News Physiol. Sci. 13, 170-176.
33. Nishi, E. E., Bergamaschi, C. T., Oliveira-Sales, E. B., Simon, K. A., and Campos, R. R. (2013). Losartan reduces oxidative stress within the rostral ventrolateral medulla of rats with renovascular hypertension. Am. J. Hypertens. 26, 858-865. doi: 10.1093/ajh/hpt037.
34. Nishi, E. E., Campos, R. R., Bergamaschi, C. T., de Almeida, V. R., and Ribeiro, D. A. (2010a). Vitamin C prevents DNA damage induced by renovascular hypertension in multiple organs of Wistar rats. Hum. Exp. Toxicol. 29, 593-599. doi: 10.1177/0960327109358267.
35. Nishi, E. E., Oliveira-Sales, E. B., Bergamaschi, C. T., Oliveira, T. G. C., Boim, M. A., and Campos, R. R. (2010b). Chronic antioxidant treatment improves arterial renovascular hypertension and oxidative stress markers in the kidney in Wistar rats. Am. J. Hypertens. 23, 473-480. doi: 10.1038/ajh.2010.11.
36. Nishihara, M., Hirooka, Y., Kishi, T., and Sunagawa, K. (2012a). Different role of oxidative stress in paraventricular nucleus and rostral ventrolateral medulla in cardiovascular regulation in awake spontaneously hypertensive rats. J. Hypertens. 30, 1758-1765. doi: 10.1097/HJH.0b013e32835613d7.
37. Nishihara, M., Hirooka, Y., Matsukawa, R., Kishi, T., and Sunagawa, K. (2012b). Oxidative stress in the rostral ventrolateral medulla modulates excitatory and inhibitory inputs in spontaneously hypertensive rats. J. Hypertens. 30, 97-106. doi: 10.1097/HJH.0b013e32834e1df4.
38. Nunes, F. C., Ribeiro, T. P., França-Silva, M. S., Medeiros, I. A., and Braga, V. A. (2010). Superoxide scavenging in the rostral ventrolateral medulla blunts the pressor response to peripheral chemoreflex activation. Brain Res. 1351, 141-149. doi: 10.1016/j.brainres.2010.07.001.
39. Oliver, J. J., Melville, V. P., and Webb, D. J. (2006). Effect of regular phosphodiesterase type 5 inhibition in hypertension. Hypertension 48, 622-627. doi: 10.1161/01.HYP.0000239816.13007.c9.
40. Oparil, S., and Schmieder, R. E. (2015). New approaches in the treatment of hypertension in metabolic diseases. Circ. Res. 116, 1074-1095. doi: 10.1161/CIRCRESAHA.116.303603.
41. Palit, V., and Eardley, I. (2010). An update on new oral PDE5 inhibitors for the treatment of erectile dysfunction. Nat. Rev. Urol. 7, 603-609. doi: 10.1038/nrurol.2010.165.
42. Queiroz, T. M., Guimarães, D. D., Mendes-Junior, L. G., and Braga, V. A. (2012). a-lipoic acid reduces hypertension and increases baroreflex sensitivity in renovascular hypertensive rats. Molecules 17, 13357-13367. doi: 10.3390/molecules171113357.
43. Raja, S. G., and Nayak, S. H. (2004). Sildenafil: emerging cardiovascular indications. Ann. Thorac. Surg. 78, 1496-1506. doi: 10.1016/j.athoracsur.2004.02.125.
44. Rodrigues, B. P., Campagnaro, B. P., Balarini, C. M., Pereira, T. M. C., Meyrelles, S. S., and Vasquez, E. C. (2013). Sildenafil ameliorates biomarkers of genotoxicity in an experimental model of spontaneous atherosclerosis. Lipids Health Dis. 12:128. doi: 10.1186/1476-511X-12-128.
45. Rossoni, G., Manfredi, B., De Gennaro Colonna, V., Berti, M., Guazzi, M., and Berti, F. (2007). Sildenafil reduces L-NAME-induced severe hypertension and worsening of myocardial ischaemia-reperfusion damage in the rat. Br. J. Pharmacol. 150, 567-576. doi: 10.1038/sj.bjp.0707131.
46. Santos, R. A. S., Ferreira, A. J., Verano-Braga, T., and Bader, M. (2013). Angiotensin-converting enzyme 2, angiotensin-(1-7) and Mas: new players of the renin-angiotensin system. J. Endocrinol. 216, R1-R17. doi: 10.1530/joe-12-0341.
47. Schäfer, A., Fraccarollo, D., Pförtsch, S., Flierl, U., Vogt, C., Pfrang, J., et al. (2008). Improvement of vascular function by acute and chronic treatment with the PDE-5 inhibitor sildenafil in experimental diabetes mellitus. Br. J. Pharmacol. 153, 886-893. doi: 10.1038/sj.bjp.0707459.
48. Shukla, N., Jones, R., Persad, R., Angelini, G. D., and Jeremy, J. Y. (2005). Effect of sildenafil citrate and a nitric oxide donating sildenafil derivative, NCX 911, on cavernosal relaxation and superoxide formation in hypercholesterolaemic rabbits. Eur. J. Pharmacol. 517, 224-231. doi: 10.1016/j.ejphar.2005.05.012.
49. Stauss, H. M., Moffitt, J. A., Chapleau, M. W., Abboud, F. M., and Johnson, A. K. (2006). Baroreceptor reflex sensitivity estimated by the sequence technique is reliable in rats. Am. J. Physiol. Heart Circ. Physiol. 291, H482-H483. doi: 10.1152/ajpheart.00228.2006.
50. Stegbauer, J., Friedrich, S., Potthoff, S. A., Broekmans, K., Cortese-Krott, M. M., Quack, I., et al. (2013). Phosphodiesterase 5 attenuates the vasodilatory response in renovascular hypertension. PLoS ONE 8:e80674. doi: 10.1371/journal.pone.0080674.
51. Stirban, A., Laude, D., Elghozi, J. L., Sander, D., Agelink, M. W., Hilz, M. J., et al. (2009). Acute effects of sildenafil on flowmediated dilatation and cardiovascular autonomic nerve function in type 2 diabetic patients. Diabetes Metab. Res. Rev. 25, 136-143. doi: 10.1002/dmrr.921.
52. Taddei, S., and Ghiadoni, L. (2006). Phosphodiesterase 5 inhibition to treat essential hypertension: is this the beginning of the story? Hypertension 48, 546-548. doi: 10.1161/01.HYP.0000241985.54400.85.
53. Terrett, N. K., Bell, A. S., Brown, D., and Ellis, P. (1996). Sildenafil (Viagra), a potent and selective inhibitor of type 5 cgmp phosphodiesterase with utility for the treatment of male erectile dysfunction. Bioorg. Med. Chem. Lett. 6, 1819-1824. doi: 10.1016/0960-894X(96)00323-X.
54. Touyz, R. M. (2004). Reactive oxygen species, vascular oxidative stress, and redox signaling in hypertension: what is the clinical significance? Hypertension 44, 248-252. doi: 10.1161/01.HYP.0000138070.47616.9d.
55. Vongpatanasin, W. (2014). Resistant hypertension: a review of diagnosis and management. JAMA 311, 2216-2224. doi: 10.1001/jama.2014.5180.
56. Walker, D. K., Ackland, M. J., James, G. C., Muirhead, G. J., Rance, D. J., Wastall, P., et al. (1999). Pharmacokinetics and metabolism of sildenafill in mouse, rat, rabbit, dog and man. Xenobiotica 29, 297-310. doi: 10.1080/004982599238687.
57. Xia, H., Sriramula, S., Chhabra, K. H., and Lazartigues, E. (2013). Brain angiotensin-converting enzyme type 2 shedding contributes to the development of neurogenic hypertension. Circ. Res. 113, 1087-1096. doi: 10.1161/CIRCRESAHA.113.301811.